Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-25-000250

Director acquired 5,349 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Grant or award : show line 1 in the form +5,349 $2.15 $11,500 140,574 D
Loading xslF345X05/wk-form4_1759522454.xml…